Kim Popovits

Kim Popovits, President and COO of Genomic Health, Inc., brings a wealth of experience from her time at Genentech. She delves into the transformative impact of molecular diagnostics in cancer care, sharing her leadership journey and the hurdles faced in launching innovative products. Kim highlights the critical engagement strategies with oncologists and the complexities of market research and reimbursement in the biopharmaceutical landscape. Her insights underscore the importance of patient care and expanding personalized medicine beyond breast cancer.